LIVER CIRRHOSIS IS INDEPENDENTLY ASSOCIATED WITH 90-DAY MORTALITY IN ARDS PATIENTS

被引:45
|
作者
Gacouin, Arnaud [1 ,2 ,3 ]
Locufier, Maxime [1 ]
Uhel, Fabrice [1 ,2 ,3 ]
Letheulle, Julien [1 ,2 ]
Bouju, Pierre [1 ,2 ]
Fillatre, Pierre [1 ,2 ]
Le Tulzo, Yves [1 ,2 ,3 ]
Tadie, Jean Marc [1 ,2 ,3 ]
机构
[1] Rennes Univ Hosp, Infect Dis & Intens Care Unit, Rennes, France
[2] Univ Rennes 1, Fac Med, Biosit, Rennes, France
[3] Univ Rennes 1, Inserm CIC 1414, Fac Med, IFR 140, Rennes, France
来源
SHOCK | 2016年 / 45卷 / 01期
关键词
Acute respiratory distress syndrome; liver cirrhosis; organ dysfunction; outcome; protective lung ventilation; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; ORGAN FAILURE; SURVIVAL; MODEL; VENTILATION; DYSFUNCTION; VALIDATION; PROGNOSIS; PRESSURE;
D O I
10.1097/SHK.0000000000000487
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background:In a few studies, cirrhosis has been associated with increased mortality in patients with acute respiratory distress syndrome (ARDS). These studies were, however, conducted mostly before 2000. Over the last 15 years, the prognosis of cirrhotic patients admitted to the intensive care unit (ICU) seems to have improved and major changes in the management of mechanical ventilation (MV) of ARDS have appeared. The aim of this study was to determine whether cirrhosis remains a factor for poor prognosis despite improvements in MV techniques and supportive therapies for ARDS.Methods:Retrospective analysis of data recorded from 232 patients (42 with cirrhosis and 290 without cirrhosis) who received lung-protective ventilation for ARDS defined according to American-European Consensus Conference criteria and admitted from 2006 to 2013. Alcohol was the most common aetiology of the cirrhosis. The end point was mortality at day-90 from the diagnosis of ARDS, survival was calculated using the Kaplan-Meier method, and we used a Cox-proportional hazard model to determine whether cirrhosis remained independently associated with mortality after adjustment for other prognostic variables for ARDS described previously. Organ dysfunctions were assessed based on the Sequential Organ Failure Assessment (SOFA) criteria, pulmonary and nonpulmonary dysfunctions were distinguished and compared between cirrhotic and non-cirrhotic patients on the first 3 days of VM.Results:Comparison of survival curves showed that cirrhotic patients had a poorer 90-day prognosis than non-cirrhotic patients (P=0.03 by the log-rank test). After adjusted analysis, cirrhosis remained independently associated with mortality at day 90 (adjusted hazard ratio 2.09, 95% CI, 1.27-3.45, P=0.004). Non-pulmonary SOFA scores were significantly higher in cirrhotic patients than in non-cirrhotic patients on day 1 (P<0.001), day 2 (P=0.003), and day 3 (P=0.002) of MV for ARDS whereas pulmonary SOFA scores did not differ significantly.Conclusions:Despite improvements in the management of cirrhotic patients admitted to the ICU and in the management of MV for the treatment of ARDS, cirrhosis remained associated with a poorer prognosis in ARDS patients. The prognosis of cirrhotic patients with ARDS appears related to extrapulmonary organ dysfunctions rather than pulmonary dysfunction.
引用
收藏
页码:16 / 21
页数:6
相关论文
共 50 条
  • [1] Baseline Neutrophil-to-Lymphocyte Ratio Is Independently Associated With 90-Day Transplant-Free Mortality in Patients With Cirrhosis
    Liu, Jing
    Li, Hai
    Xia, Jie
    Wang, Xianbo
    Huang, Yan
    Li, Beiling
    Meng, Zhongji
    Gao, Yanhang
    Qian, Zhiping
    Liu, Feng
    Lu, Xiaobo
    Liu, Junping
    Deng, Guohong
    Zheng, Yubao
    Yan, Huadong
    Qiao, Liang
    Xiang, Xiaomei
    Zhang, Qun
    Chen, Ruochan
    Chen, Jinjun
    Luo, Sen
    Gao, La
    Ji, Liujuan
    Li, Jing
    Zhou, Xinyi
    Ren, Haotang
    Lu, Sihong
    Li, Sumeng
    Zhang, Weituo
    Zheng, Xin
    FRONTIERS IN MEDICINE, 2021, 8
  • [2] The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality
    Taylor, N. J.
    Vijay, G. K. Manakkat
    Abeles, R. D.
    Auzinger, G.
    Bernal, W.
    Ma, Y.
    Wendon, J. A.
    Shawcross, D. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 705 - 715
  • [3] 48 hours of cisatracurium reduced 90-day mortality in patients with early, severe ARDS
    Sevransky, Jonathan
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (02)
  • [4] Development of a nomogram for predicting 90-day mortality in patients with sepsis-associated liver injury
    Cui, Liangwen
    Bao, Junjie
    Yu, Chao
    Zhang, Cheng
    Huang, Rui
    Liu, Lian
    Shao, Min
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Development of a nomogram for predicting 90-day mortality in patients with sepsis-associated liver injury
    Liangwen Cui
    Junjie Bao
    Chao Yu
    Cheng Zhang
    Rui Huang
    Lian Liu
    Min Shao
    Scientific Reports, 13
  • [6] Scoring system for predicting 90-day mortality of in-hospital liver cirrhosis patients at Cipto Mangunkusumo Hospital
    Irsan Hasan
    Saut Horas Hatoguan Nababan
    Anugrah Dwi Handayu
    Gita Aprilicia
    Rino Alvani Gani
    BMC Gastroenterology, 23
  • [7] Scoring system for predicting 90-day mortality of in-hospital liver cirrhosis patients at Cipto Mangunkusumo Hospital
    Hasan, Irsan
    Nababan, Saut Horas Hatoguan
    Handayu, Anugrah Dwi
    Aprilicia, Gita
    Gani, Rino Alvani
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [8] Biomarkers associated with 90-day mortality in patients with intracerebral haemorrhage (ICH)
    Florczak-Rzepka, M.
    Steiner, Th.
    CEREBROVASCULAR DISEASES, 2013, 35 : 226 - 226
  • [9] Braden score can independently predict 90-day mortality in critically ill patients with dementia
    Cheng, Hongtao
    Li, Xinya
    Liang, Xin
    Tang, Yonglan
    Wei, Fangxin
    Wang, Zichen
    Lyu, Jun
    Wang, Yu
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 39 (05)
  • [10] Patients with diabetes are at higher risk of 90-day mortality following liver resection
    Ghosh, S.
    Dasari, B.
    Marudanayagam, R.
    Sutcliffe, R.
    Roberts, K.
    Mirza, D.
    Muiesan, P.
    Isaac, J.
    Hanif, W.
    DIABETIC MEDICINE, 2018, 35 : 157 - 157